placing the Q1 modifier doesn't reduce re-imbursement. As far as placing the modifier with the V70.7 code on each line item, this has been an uncleared question and response from CMS. As a member of the POE chapter of medicare, I have requested a webcast on billing clinical trials. My understanding since the year 2000 and 2007, the modifier with the V70.7 was placed on the administration charge only that is identified as routine cost. the modifier Q0 with the V70.7 is placed on the services that are identified as non-routine cost not affiliated with routine chemotherapy regimens, such U/A. I believe we are probably reading the same CMS guidelines which are confusing to a "coder's language". Looking forward to additional input.
- ICD-10 Trainings
- Comprehensive Courses
- CPC (Certified Professional Coder)
- COC (Certified Outpatient Coder)
- CIC (Certified Inpatient Coder) NEW!
- CRC (Certified Risk Adjustment Coder) NEW!
- CPB (Certified Professional Biller)
- CPMA (Certified Professional Medical Auditor)
- CDEO (Certified Documentation Expert – Outpatient) NEW!
- CPPM (Certified Physician Practice Manager)
- CPCO (Certified Professional Compliance Officer)
- VIEW ALL CERTIFICATIONS
Coding / Billing Solutions
- Audit / Compliance Solutions
Job Experience / Apprentice Removal
News / Discussion
- Other Resources
- Book Store
- Log In / Join